D89.83
Cytokine release syndrome
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
Code First
- underlying cause, such as:
- complications following infusion, transfusion and therapeutic injection (T80.89-)
- complications of transplanted organs and tissue (T86.-)
Medical Intelligence & Overview
Cytokine Release Syndrome (CRS) is a condition caused by a large, rapid release of cytokines into the bloodstream. Cytokines are proteins produced by your immune system to help fight infections and respond to immune challenges. While cytokines play a vital role in immune defense, an excessive release can lead to systemic inflammation, affecting multiple organs and tissues. CRS can occur in response to certain medical treatments, infections, or immune disorders, and its severity can vary widely from mild flu-like symptoms to life-threatening complications.
Causes & Symptoms
Clinical Causes: Biological therapies such as CAR T-cell therapy or monoclonal antibodies used in cancer treatment Severe infections, including viral infections like COVID-19 or influenza Certain autoimmune diseases where the immune system is hyperactive Exposure to specific genetically engineered or immunomodulating agents Other medical interventions that activate the immune system strongly
Key Symptoms: Fever and chills Fatigue or weakness Swelling or edema Muscle or joint pain Rash or skin redness Shortness of breath or difficulty breathing Hypotension (low blood pressure) Tachycardia (rapid heartbeat) Nausea or vomiting Confusion or altered mental state Organ dysfunction in severe cases, affecting organs such as the liver, kidneys, or heart
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cytokine release syndrome involves a combination of clinical evaluation and laboratory tests. Healthcare providers look for characteristic symptoms such as high fever, hypotension, and respiratory issues, especially in individuals undergoing treatments associated with CRS. Blood tests may reveal elevated levels of cytokines, increased inflammation markers, and abnormalities in organ function. Imaging studies or other diagnostic procedures might be performed if organ involvement is suspected. Prompt recognition is crucial for effective management.
Treatment Protocols: Hospital admission for close monitoring Administering fluids and electrolytes to maintain blood pressure and hydration Use of antipyretics to control fever Steroids such as corticosteroids to suppress immune response Medications like tocilizumab or siltuximab that specifically inhibit cytokine activity Oxygen therapy or mechanical ventilation in cases of respiratory failure Treating any underlying infections or triggers contributing to CRS
Clinical Advice & FAQs
Billing Guidance
Is D89.83 a billable ICD-10 code?
Yes, D89.83 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.83?
Clinical documentation must specify the nature of Cytokine release syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference